Health Trials

Intermittent Fasting, Mediterranean Diet and NAFLD

ConditionsNAFLDObesityIntermittent FastingMediterranean Diet
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age30-65
SponsorAzienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis

About this trial

This study aims to evaluate the effects of Intermittent Fasting (IF) 14/10 compared with the Low Glycemic Index Mediterranean Diet on NAFLD.

Eligibility criteria

Qualifiers

Medium/severe NAFLD (CAP>268)

BMI between 25 and 35

Disqualifiers

diabetes treated with insulin,

fatty liver disease linked to alcohol consumption,

chronic inflammatory intestinal and oncological diseases,

visceral obesity which does not allow good resolution of Fibroscan images,

Trial design

Treatments tested in this trial

  • Intermittent Fasting

Treatment groups

60 Participants
are divided into 2 treatment groups

Locations

This trial has no locations

Sponsors and collaborators

Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis

Lead sponsor

Source ClinicalTrials.gov